Cart
×
Investment to Expand First-in-Class, Nucleic Acid Therapeutics Towards Targeting Muscle Diseases Newport Beach, Calif. (December 22, 2021) – CureDuchenne Ventures, a subsidiary of CureDuchenne, a leading global nonprofit focused on […]